29, 1-st Brestskaya Street,
Business-center "Capital Tower", level 8
Moscow, Russia, 125047
+7 495 545-39-12
Show RusnanoMedInvest in a large map
Pfizer Inc, one of the world’s premier biopharmaceutical companies and NovaMedica, a Russian pharmaceutical company established by Rusnano and Domain Associates, have completed the last stage of negotiations for a long-term strategic partnership designed to transfer the rights and technologies for the production of more than 30 life-saving and essential drugs from the Pfizer product portfolio. The deal will enable Pfizer and NovaMedica to improve the health of patients in Russia and modernize the Russian pharmaceutical industry.
26 April 2017
25 April 2017